Publications

5439 Results

Studies of some newer phosphoramide mustards.

Authors
OM Friedman
Journal / Conference
Cancer Chemotherapy Reports 51:347-357
Year
1967

Recent biologic and chemical studies of cyclophosphamide (NSC-26271).

Authors
OM Friedman
Journal / Conference
Cancer Chemotherapy Reports 51:327-333
Year
1967

Cyclophosphamide (NSC-26271) in the treatment of children with malignant neoplasm.

Authors
ME Haggard
Journal / Conference
Cancer Chemotherapy Reports 51:403-405
Year
1967

Pharmacologic studies of cyclophosphamide (NSC-26271) and its cogener phosphoramide mustard (NSC-69945).

Authors
TC Hall
Journal / Conference
Cancer Chemotherapy Reports 51:335-340
Year
1967

Treatment of neuroblastoma in children by a cyclic program of vincristine (NSC-67574) and cyclophosphamide (NSC- 26271).

Authors
DH James Jr
Journal / Conference
Cancer Chemotherapy Reports 51: 411-412
Year
1967
Research Committee(s)
Brain

Urinary excretion of cyclophosphamide (NSC-26271) and its metabolites: Evidence for the existence of an "active" cyclic metabolite.

Authors
AN Milner;MP Sullivan
Journal / Conference
Cancer Chemotherapy Reports 51:343-345
Year
1967

Cyclophosphamide (NSC-26271) therapy for children with neuroblastoma.

Authors
WG Thurman;MG Donaldson
Journal / Conference
Cancer Chemotherapy Reports 51:399-401
Year
1967
Research Committee(s)
Brain

Cyclophosphamide treatment for metastatic soft tissue sarcoma.

Authors
TB Haddy;AH Nora;WW Sutow;TJ Vietti
Journal / Conference
Am J Dis Child 114:301-308
Year
1967
Research Committee(s)
Sarcoma

Cyclophosphamide (NSC-26271) in Wilms' tumor and rhabdomyosarcoma.

Authors
WW Sutow
Journal / Conference
Cancer Chemotherapy Reports 51:407-409
Year
1967
Research Committee(s)
Sarcoma

Melphalan (NSC-8806) in advanced breast cancer

Authors
ME Sears;A Haut;N Eckles
Journal / Conference
Cancer Chemotherapy Reports 50:271-279
Year
1966
Research Committee(s)
Breast